跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Coglitazone 30
Approved
STANDARD
Coglitazone 30
Umedica Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
72de645f7405167c
Company
Umedica Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
72de645f7405167c
Drug Approval Philippines Name
Coglitazone 30
Product Name
Coglitazone 30
Registration Number
DRP-1184-03
Brand Name
Coglitazone 30
Generic Name
Pioglitazone (as hydrochloride)
Dosage Form
Tablet
Dosage Strength
30 mg
Manufacturer
Umedica Laboratories Pvt. Ltd.
Importer
Suhitas Pharmaceuticals Inc
Distributor
Applied Pharmaceutical Distribution Inc
Company Detail Path
/organization/umedica-laboratories-pvt-ltda
Issuance Date
26 April 2024
Expiry Date
16 December 2028
Pharmacologic Category
Oral Hypoglycemic Agent
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
72de645f7405167c
Type
Standard
Back to Philippines FDA Approvals
Coglitazone 30 - Philippines FDA Drug Approval Details